Cargando…

Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study

BACKGROUND: The metabolism of many proton pump inhibitors is influenced by CYP2C19 genotype, which is a limitation of their use. OBJECTIVES: To determine the efficacy and safety profile of Z-215 (azeloprazole sodium) as initial treatment for reflux esophagitis (RE), dose response, and optimal dose c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Yoshikazu, Kusano, Motoyasu, Iwakiri, Katsuhiko, Fujishiro, Mitsuhiro, Tachikawa, Naoto, Haruma, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054772/ https://www.ncbi.nlm.nih.gov/pubmed/30038671 http://dx.doi.org/10.1016/j.curtheres.2018.03.004

Ejemplares similares

Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2017)

Therapeutic Response to Twice-daily Rabeprazole on Health-related Quality of Life and Symptoms in Patients with Refractory Reflux Esophagitis: A Multicenter Observational Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2017)

Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito
por: Sakata, Yasuhisa, et al.
Publicado: (2014)

Stability-indicating HPLC–DAD methods for determination of two binary mixtures: Rabeprazole sodium–mosapride citrate and rabeprazole sodium–itopride hydrochloride
por: El-Fatatry, Hamed M., et al.
Publicado: (2014)

A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis
por: Nagahara, Akihito, et al.
Publicado: (2013)

Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison
por: Furuta, Kenji, et al.
Publicado: (2014)

Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole
por: Bae, Sungyeun, et al.
Publicado: (2023)

Quantitative Estimation of Itopride Hydrochloride and Rabeprazole Sodium from Capsule Formulation
por: Pillai, S., et al.
Publicado: (2008)

Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial
por: Fujishiro, Mitsuhiro, et al.
Publicado: (2015)

Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Gastrointestinal bleed induced by a fixed dose combination of rabeprazole and diclofenac sodium
por: Tandon, Vishal R., et al.
Publicado: (2014)

Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone
por: Iida, Hiroshi, et al.
Publicado: (2017)

Sex differences in risk factors for future onset of reflux esophagitis
por: Osaga, Satoshi, et al.
Publicado: (2021)

Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance
por: Tirpude, Rakesh N., et al.
Publicado: (2011)

Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules
por: Tan, Yinhe, et al.
Publicado: (2016)

Quality by Design Applied Development of Immediate-Release Rabeprazole Sodium Dry-Coated Tablet
por: Lee, Sang-Ho, et al.
Publicado: (2021)

Clinical features and therapeutic responses to proton pump inhibitor in patients with severe reflux esophagitis: A multicenter prospective observational study
por: Isshi, Kimio, et al.
Publicado: (2020)

Spectrophotometric methods for simultaneous estimation of rabeprazole sodium and aceclofenac from the combined capsule dosage form
por: Sawant, Ramesh L., et al.
Publicado: (2011)

Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational study
por: Manabe, Noriaki, et al.
Publicado: (2022)

Liquid-containing Refluxes and Acid Refluxes May Be Less Frequent in the Japanese Population Than in Other Populations: Normal Values of 24-hour Esophageal Impedance and pH Monitoring
por: Kawamura, Osamu, et al.
Publicado: (2016)

Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018)

The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease
por: Chen, Ying, et al.
Publicado: (2013)

Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms
por: Nakada, Koji, et al.
Publicado: (2017)

Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux
por: Shin, Myung-Hee, et al.
Publicado: (2012)

A Randomized, Double Blinded, Clinical Trial to Assess the Efficacy and Cost Effectiveness of Omeprazole Compared to Rabeprazole in the Maintenance Therapy of Patients With Gastroesophageal Reflux Disease
por: Park, Jung Ho, et al.
Publicado: (2013)

An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease
por: Zouboulis-Vafiadis, Irini, et al.
Publicado: (2014)

Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2019)

Rabeprazole Coadministration Controls Ulcer Recurrence in Patients on Low-dose Aspirin Therapy: A Multicenter Prospective Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2022)

Optical pumping of sodium vapour
por: Levy, C D P, et al.
Publicado: (1984)

Regulation of the cardiac sodium pump
por: Fuller, W., et al.
Publicado: (2012)

Is the Second Sodium Pump Electrogenic?
por: Thomas, L. E., et al.
Publicado: (2013)

Structural insights into sodium transport by the oxaloacetate decarboxylase sodium pump
por: Xu, Xin, et al.
Publicado: (2020)

Validation and Application of a New Reversed Phase HPLC Method for In Vitro Dissolution Studies of Rabeprazole Sodium in Delayed-Release Tablets
por: Nawaz, Md. Saddam
Publicado: (2013)

Trends in proton pump inhibitor use, reflux esophagitis, and various upper gastrointestinal symptoms from 2010 to 2019 in Japan
por: Yamamichi, Nobutake, et al.
Publicado: (2022)

Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2016)

Functional characterization of sodium-pumping rhodopsins with different pumping properties
por: Tsunoda, Satoshi P., et al.
Publicado: (2017)

Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation
por: Kumar, Navneet, et al.
Publicado: (2013)

Sodium and potassium fluxes and membrane potential of human neutrophils: evidence for an electrogenic sodium pump
Publicado: (1982)

Sodium pump-mediated ATP:ADP exchange. The sided effects of sodium and potassium ions
Publicado: (1982)

Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumps
por: Gould, Harry J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jb6uh0c7ek2749be63lci9g7gl